CurrentRheuma
Get Weekly

CurrentRheuma coverage · page 44 of 48

Rheumatology (Oxford)

Briefs 1,721–1,760 of 1,905 CurrentRheuma has covered from this journal, newest publication first

Latest from Rheumatology (Oxford)

All coverage, newest first

  1. Rheumatology (Oxford)

    Comprehensive and reliable sonographic assessment and scoring system for inflammatory lesions of the paediatric ankle

    Guideline or statementPediatric

  2. Rheumatology (Oxford)

    Deep stratification by transcriptome molecular characters for precision treatment of patients with systemic lupus erythematosus

    Mechanistic studyLupus & APS

  3. Rheumatology (Oxford)

    External validation of the alternative Ankylosing Spondylitis Disease Activity Score in three randomized clinical trials of ixekizumab

    Diagnostic or prognostic studySpondyloarthritis & PsA

  4. Rheumatology (Oxford)

    Efficacy and safety of risankizumab for active psoriatic arthritis: 52-week results from the KEEPsAKE 2 study

    Randomized controlled trialSpondyloarthritis & PsA

  5. Rheumatology (Oxford)

    Efficacy and safety of risankizumab for active psoriatic arthritis: 52-week results from the KEEPsAKE 1 study

    Randomized controlled trialSpondyloarthritis & PsA

  6. Rheumatology (Oxford)

    Inactivated SARS-CoV-2 vaccine does not increase the risk of relapse in patients with clinically inactive adult-onset Still’s disease

    Cohort studyAutoinflammatory & rare

  7. Rheumatology (Oxford)

    The adjusted Global Anti-Phospholipid Syndrome Score as predictor of damage accrual measured by Damage Index for APS: a longitudinal study

    Cohort studyLupus & APS

  8. Rheumatology (Oxford)

    COVID-19 vaccination in systemic lupus erythematosus: a systematic review of its effectiveness, immunogenicity, flares and acceptance

    Meta-analysisLupus & APS

  9. Rheumatology (Oxford)

    Assessment and diagnosis of the acute hot joint: a systematic review and meta-analysis

    Meta-analysis

  10. Rheumatology (Oxford)

    Grit personality of physicians and achievement of treatment goals in patients with system lupus erythematosus

    Cross-sectional studyLupus & APS

  11. Rheumatology (Oxford)

    Citrullinated and carbamylated proteins in extracellular microvesicles from plasma of patients with rheumatoid arthritis

    Mechanistic studyRA

  12. Rheumatology (Oxford)

    Angiotensin receptor blockade is associated with increased risk of giant cell arteritis

    Cohort studyVasculitis & PMR

  13. Rheumatology (Oxford)

    The association between autoantibodies and risk for venous thromboembolic events among patients with rheumatoid arthritis

    Cohort studyRA

  14. Rheumatology (Oxford)

    Anti-transcription intermediary factor 1-gamma IgG2 isotype is associated with cancer in adult dermatomyositis: an ENMC multinational study

    Cohort studyMyositis

  15. Rheumatology (Oxford)

    Genetic architecture underlying IgG-RF production is distinct from that of IgM-RF

    Case-control studyRA

  16. Rheumatology (Oxford)

    Humoral and cellular immunity in patients with rare autoimmune rheumatic diseases following SARS-CoV-2 vaccination

    Cohort studyAcross diseases

  17. Rheumatology (Oxford)

    Antiphospholipid antibody positivity in early systemic lupus erythematosus is associated with subsequent vascular events

    Cohort studyLupus & APS

  18. Rheumatology (Oxford)

    Functional autoantibodies in systemic sclerosis: influence of autologous stem cell transplantation and correlation with clinical outcome

    Cohort studySystemic sclerosis

  19. Rheumatology (Oxford)

    Biologics with or without methotrexate in treatment of polyarticular juvenile idiopathic arthritis: effectiveness, safety and drug survival

    Cohort studyPediatric

  20. Rheumatology (Oxford)

    Systemic sclerosis-associated interstitial lung disease in the EUSTAR database: analysis by region

    Cohort studySystemic sclerosis

  21. Rheumatology (Oxford)

    Nationwide racial/ethnic disparities in US emergency department visits and hospitalizations for gout

    Cross-sectional studyGout & crystals

  22. Rheumatology (Oxford)

    Development of a scoring model for the Sharp/van der Heijde score using convolutional neural networks and its clinical application

    Cohort studyRA

  23. Rheumatology (Oxford)

    Favourable effect of a ‘second hit’ after 13 weeks in early RA non-responders: the Amsterdam COBRA treat-to-target randomized trial

    Randomized controlled trialRA

  24. Rheumatology (Oxford)

    Added diagnostic yield of temporal artery magnetic resonance angiography in the evaluation of giant cell arteritis

    Cohort studyVasculitis & PMR

  25. Rheumatology (Oxford)

    The effect of anti-inflammatory treatment on depressive symptoms in spondyloarthritis: does the type of drug matter?

    Cohort studySpondyloarthritis & PsA

  26. Rheumatology (Oxford)

    Performance of an MRI scoring system for inflammation of joints and entheses in peripheral SpA: post-hoc analysis of the CRESPA trial

    Secondary analysisSpondyloarthritis & PsA

  27. Rheumatology (Oxford)

    Revisiting idiopathic eosinophilic myositis: towards a clinical-pathological continuum from the muscle to the fascia and skin

    Cohort studyMyositis

  28. Rheumatology (Oxford)

    Comparison of health-care utilization, costs and health-related quality of life across the subgroups defined by the Keele STarT MSK Tool

    Cohort studyFibromyalgia & pain

  29. Rheumatology (Oxford)

    Cutaneous vasculitis occurring in the setting of systemic lupus erythematosus: a multicentre cohort study

    Cohort studyLupus & APS

  30. Rheumatology (Oxford)

    Non-trough adalimumab and certolizumab drug levels associated with a therapeutic EULAR response in adherent patients with rheumatoid arthritis

    Cohort studyRA

  31. Rheumatology (Oxford)

    Determination of four homogeneous subgroups of patients with antiphospholipid syndrome: a cluster analysis based on 509 cases

    Cohort studyLupus & APS

  32. Rheumatology (Oxford)

    Early characterization of difficult-to-treat rheumatoid arthritis by suboptimal initial management: a multicentre cohort study

    Cohort studyRA

  33. Rheumatology (Oxford)

    Trust in the attending rheumatologist, health-related hope and medication adherence among Japanese systemic lupus erythematosus patients

    Cross-sectional studyLupus & APS

  34. Rheumatology (Oxford)

    Baseline knee extension may be associated with volumetric cartilage loss in the anterolateral tibia: data from the Osteoarthritis Initiative

    Cross-sectional studyOsteoarthritis

  35. Rheumatology (Oxford)

    Association between beverage consumption and risk of rheumatoid arthritis: a prospective study from the French E3N Cohort

    Cohort studyRA

  36. Rheumatology (Oxford)

    Systemic sclerosis associated interstitial lung disease: a conceptual framework for subclinical, clinical and progressive disease

    Guideline or statementSystemic sclerosis

  37. Rheumatology (Oxford)

    Improved sensitivity of the skin pathergy test with polysaccharide pneumococcal vaccine antigens in the diagnosis of Behçet disease

    Diagnostic or prognostic studyVasculitis & PMR

  38. Rheumatology (Oxford)

    A novel long non-coding RNA, lnc-RNU12, influences the T-cell cycle via c-JUN and CCNL2 in rheumatoid arthritis

    Mechanistic studyRA

  39. Rheumatology (Oxford)

    Development of prediction models to select older RA patients with comorbidities for treatment with chronic low-dose glucocorticoids

    Secondary analysisRA

  40. Rheumatology (Oxford)

    Continuing specialist care into adulthood in young people with juvenile idiopathic arthritis: a retrospective cohort study using electronic health records in England

    Cohort studyPediatric

All 1,905 Briefs in ExploreShowing Briefs 1,721–1,760 of 1,905, newest first